Page last updated: 2024-11-04

rolipram and Leukemia, Monocytic, Acute

rolipram has been researched along with Leukemia, Monocytic, Acute in 1 studies

Leukemia, Monocytic, Acute: An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES.

Research Excerpts

ExcerptRelevanceReference
"Rolipram was added along with LPS after PMA differentiation to assess the response of cells to the anti-inflammatory agent."1.46[Optimization and evaluation of an inflammatory cell model in LPS-stimulated PMA-differentiated THP-1 cells]. ( Jing, Y; Liao, F; Rao, J; Xi, L; Yang, X; Zou, M, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zou, M1
Xi, L1
Rao, J1
Jing, Y1
Liao, F1
Yang, X1

Other Studies

1 other study available for rolipram and Leukemia, Monocytic, Acute

ArticleYear
[Optimization and evaluation of an inflammatory cell model in LPS-stimulated PMA-differentiated THP-1 cells].
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2017, Volume: 33, Issue:11

    Topics: Anti-Inflammatory Agents; Cell Differentiation; Humans; Inflammation Mediators; Interleukin-6; Leuke

2017